A 7.84% single-day slide in Americold Realty Trust’s share price has triggered a formal investigation by Pomerantz LLP. The firm is currently probing whether the real estate investment trust or its leadership misled shareholders regarding business practices, following a massive impairment charge linked to a terminated distribution contract.
A 35% single-day stock collapse following a major revenue miss has triggered a formal investigation by Pomerantz LLP into Parsons Corporation. The New York-based law firm is examining whether the company or its leadership engaged in securities fraud or unlawful business practices following July’s disappointing financial disclosures.
Meta’s $18 billion settlement over youth safety features on Facebook and Instagram marks a pivot in the social media industry, forcing a transition from optional safeguards to structural changes. For critics and competitors like UP, Inc., this legal reckoning signals that the era of engagement-at-all-costs is facing a definitive regulatory challenge.
Timed to the Anime NYC convention, Cineverse-owned RetroCrush has finalized a content acquisition agreement with VIZ Media. The deal brings a host of legendary anime titles—including major franchise entries from Naruto, BLEACH, and Pretty Guardian Sailor Moon—to the streaming platform for the first time in its history.
A 25.8% surge in American horses exported for slaughter last year, totaling over 25,000 animals, has reignited demands for federal intervention. Return to Freedom Wild Horse Conservation is pushing for the SAFE Act, arguing that current Bureau of Land Management policies fail to prevent protected animals from reaching foreign abattoirs.
Investors who purchased The Simply Good Foods Company securities face an October 13, 2026, deadline to seek appointment as lead plaintiff in a class action lawsuit. The litigation centers on allegations of securities fraud linked to undisclosed product quality issues and subsequent financial downturns.
A federal class action lawsuit now targets Blaize Holdings, Inc. following allegations that the company inflated its share price through a questionable business deal. Investors who suffered financial losses after the company’s April 2026 stock tumble have until October 5 to petition the court for lead plaintiff status.
Tampa General Hospital and the University of South Florida have secured a $150,000 grant to establish the Center for Lymphatic Education and Research. The new initiative aims to bridge the gap between clinical practice and scientific inquiry, addressing the systemic underfunding and lack of awareness surrounding chronic lymphatic diseases.
Niels Troost, The Arkin Group, and Victoria Kataoka have reached a settlement ending their mutual litigation over contentious remarks made at a 2024 London conference and on a 2025 podcast. The resolution follows the disclosure of previously unavailable recordings that prompted a reversal of prior claims regarding an alleged disinformation campaign.
Investors who suffered losses in Taboola.com Ltd. shares now face an October 20, 2026, deadline to seek appointment as lead plaintiff in a newly filed securities fraud class action. The litigation centers on the company’s recent financial performance and disclosures regarding its publisher relationships and revenue guidance.
Investors who suffered significant losses in Genius Group Limited securities between April 2022 and May 2025 have until August 28, 2026, to file as lead plaintiffs. The class action litigation targets Citadel Securities LLC and Virtu Americas LLC over allegations of systematic market manipulation.
A federal class action lawsuit now targets iTonic Holdings Ltd, formerly known as Pheton Holdings, following accusations that the company’s leadership and underwriters orchestrated a massive stock manipulation scheme. Investors who suffered losses have until September 28, 2026, to seek appointment as lead plaintiff in the ongoing litigation.
A federal class action lawsuit has been filed against Capricor Therapeutics, alleging the company misled investors regarding the clinical efficacy of its Duchenne muscular dystrophy treatment, deramiocel. The litigation follows a sharp decline in share price triggered by critical FDA findings concerning the firm's statistical analysis practices.
Investors who suffered losses in Rackspace Technology, Inc. are being urged to join a newly filed class action lawsuit as the firm investigates potential securities fraud. The legal action follows a sharp 33.6% drop in share price triggered by a significant reduction in the company's full-year financial outlook.
A federal class action lawsuit targets Park Ha Biological Technology following allegations that the company’s stock price was artificially inflated through a sophisticated pump-and-dump scheme. Investors who purchased shares during the class period now face a September 28, 2026, deadline to petition the court for lead plaintiff status.
Investors who suffered losses in Bloom Energy Corporation are now being recruited for a class action lawsuit following claims that the company misled stakeholders about its supply chain. The litigation focuses on allegations that Bloom relied on restricted Chinese scandium despite contrary assurances provided to the market.
The National Institute for Health and Care Excellence has issued guidance recommending routine NHS funding for ex-situ machine perfusion devices, including Bridge to Life’s VitaSmart system. The decision marks a shift toward hypothermic oxygenated perfusion as a standard of care for preserving deceased donor livers prior to transplantation.
Investors in HDFC Bank are facing a critical deadline as a class action lawsuit moves forward against the financial giant. The litigation follows a series of executive departures and reports of irregular financial practices that triggered significant drops in the bank’s American Depositary Shares earlier this year.
Conflict has erupted between the Building Industry Association of Southern California and the Southern California Association of Governments over Senate Bill 1087. While a broad coalition of regional agencies and businesses has turned against the legislation, SCAG leadership continues to sponsor the bill, sparking a push for systemic governance reform.
Investors who held Smartsheet stock between June and September 2024 are being urged to join a class action lawsuit filed by Pomerantz LLP. The litigation centers on claims that the company repurchased its own shares at deflated market prices while withholding knowledge of a lucrative pending takeover bid from private equity firms.
Investors who suffered losses on Alibaba Group Holding Limited stock are now facing an October 5, 2026, deadline to join a class action lawsuit. The litigation centers on allegations of securities fraud, triggered by a series of market-moving controversies involving U.S. government blacklisting and claims of illicit AI model access.
A federal class action lawsuit now targets ARS Pharmaceuticals, alleging the company misled investors regarding insurance coverage for its flagship epinephrine nasal spray, neffy. The legal action follows a sharp stock decline triggered by news that CVS Caremark delayed a critical coverage decision until at least early 2027.
Investors who purchased TruGolf Holdings, Inc. securities are facing significant losses as a new class action lawsuit alleges the company misled shareholders regarding its capital structure and financial reporting. The complaint centers on claims that the firm failed to disclose massive share dilution and inaccuracies in its public filings.
A 20.8% single-day collapse in stock value triggered by federal enforcement action against Alarum Technologies Ltd. has prompted a class action lawsuit. Investors now have until October 5, 2026, to seek lead plaintiff status in a case examining whether the company engaged in securities fraud through its NetNut subsidiary.
Investors who suffered losses in Pentair plc are weighing legal action after the company’s stock plunged 15 percent in July. Pomerantz LLP has filed a class action lawsuit, alleging the firm and its leadership engaged in securities fraud following a dramatic revision of financial guidance and an unexpected executive departure.
A 34.78% share price collapse on August 6, 2026, has triggered a class action lawsuit against UWM Holdings Corporation. Investors allege the mortgage giant engaged in securities fraud, citing heavy financial losses tied to a botched acquisition attempt of Two Harbors Investment Corp. that left the company over-hedged.
A federal class action lawsuit now targets Replimune Group, Inc. following a sharp decline in share price triggered by the FDA’s rejection of its lead cancer therapy. Investors who acquired securities during the designated class period face an October 5, 2026, deadline to seek appointment as lead plaintiff in the litigation.
Investors who held DNOW Inc. common stock ahead of the company's September 2025 merger with MRC Global Inc. are now the subject of a class action lawsuit. The complaint alleges that leadership misled shareholders by concealing significant technical failures within MRC’s enterprise resource planning system during the acquisition process.
A 14.28% plunge in GoDaddy stock on February 25, 2026, has triggered a class action lawsuit led by Pomerantz LLP. The legal action targets the company and its leadership, alleging securities fraud following a sharp deceleration in bookings that blindsided analysts and investors during the final quarter of 2025.
A federal class action lawsuit has been launched against Wise Group plc following a series of regulatory setbacks and criminal investigations. Investors who incurred losses during the specified class period now face a September 29, 2026, deadline to petition the court for appointment as lead plaintiff in the ongoing litigation.
